For research use only. Not for therapeutic Use.
4-Thio-2’-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Catalog Number | I041249 |
CAS Number | 5580-20-1 |
Synonyms | 1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidenepyrimidin-2-one |
Molecular Formula | C9H12N2O4S |
Purity | ≥95% |
InChI | InChI=1S/C9H12N2O4S/c12-4-6-5(13)3-8(15-6)11-2-1-7(16)10-9(11)14/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,16)/t5?,6-,8-/m1/s1 |
InChIKey | PHNDUXLWAVSUAL-KYVYOHOSSA-N |
SMILES | C1C(C(OC1N2C=CC(=S)NC2=O)CO)O |
Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |